期刊文献+

血清淀粉样蛋白A在肾移植术后排斥反应诊断中的价值 被引量:6

Value of Serum Amyloid in Diagnosis of Rejection after Kidney Transplantation
下载PDF
导出
摘要 目的探讨血清淀粉样蛋白A(SAA)在肾移植术后排斥反应诊断中的价值。方法应用BNproSpec特定蛋白检测仪检测肾移植患者6例及健康者50例血清SAA、C反应蛋白(CRP)的含量。应用日立7600型全自动生化分析仪检测Bu、Cr的含量。结果健康者血清SAA平均值为2.49mg/L。肾移植患者术前血清SAA均值为11.0mg/L,术后第6-10天血清SAA达到峰值。术后发生排斥反应时,SAA水平明显升高且早于Cr水平的升高。结论肾移植术后血清SAA的异常升高较血清Cr更为敏感,可用于肾移植术后急性排斥反应的预测。 Objective To study the value of serum amyloid (SAA) in diagnosis of rejection after kidney transplantation. Methotis The levels of SAA and CRP were determined by BN proSpec in 6 patients after kidney transplantation and 50 healthy people. The levels of Bu and Cr were determined by hatachi-7600 fully automatic biochemical analyzer. Results The average level of SAA in the healthy group was 2.49 mg/L. The average level of SAA in 6 patients before kidney transplantation was 11.0 mg/L. From 6 to 10 days after kidney transplantation, the level of SAA increased to the highest level. The level of SAA increased significantly when acute rejection was happened,and it was more sensitive than Cr. Conclusion The increase of SAA is more sensitive than Cr after kidney transplantation, and it can indicate acute renal rejection after kidney transplantation.
出处 《中国实验诊断学》 北大核心 2010年第2期242-243,共2页 Chinese Journal of Laboratory Diagnosis
关键词 肾移植 血清淀粉样蛋白A kidney transplantation SAA
  • 相关文献

参考文献4

  • 1Uguccioni M, Meliconi R, Lalli E, et al. Serum amyloid A protein concefitrations in bone marrow transplantation for β thalassaemia [ J ]. J Clin Pathol, 1992,45 : 348.
  • 2Malle E, DeBeer FC. Human Serum Amyloid (SAA) protein: a prominent acute phase reactant for chnical practice [J]. Eur J Clin Invest, 1996, 126:427.
  • 3Male E, Steinmetz A, Raynes JG. Serum amyloid A(SAA ) : an acute phase protein and apolipoprotein [ J ]. Atherosclerosis, 1993,102:131.
  • 4郭品娥,沈茜,许育,周岳松.血清淀粉样蛋白A在肾移植排异反应诊断中的作用[J].上海医学检验杂志,2002,17(5):271-273. 被引量:3

二级参考文献6

  • 1Malle E, DeBeer FC. Human Serum Amyloid(SAA) protein: a prominent acute-phase reactant for clinical practice[J]. Eur J Clin Invest, 1996,126:427-435.
  • 2Malle E, Steinmetz A, Raynes JG. Serum amyloid A(SAA): an acute phase protein and apolipoprotein[J]. Atherosclerosis, 1993,102:131-146.
  • 3Feussuer G, Stech C, Dobmeyer J, et al. Serum amyloid A protein(SAA): a marker for liver allograft rejection in humans[J]. Clin Invest, 1994,72:107-1011.
  • 4Uguccioni M, Meliconi R, Lalli E, et al. Serum amyloid A protein concentrations in bone marrow transplantation for β thalassaemia[J]. J Clin Pathol, 1992,45:348-351.
  • 5Hartmann A, Eide TC, Fauchald P, et al. Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejection[J]. Nephrol Dial Transplant, 1997,12:161-166.
  • 6Yamade T. Serum Amyloid A(SAA): A concise review of biology, assay methods and clinical usefulness[J]. Clin Chem Lab Med, 1999,37:381-388.

共引文献2

同被引文献83

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部